US Broker Ratings

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 46.89% Potential Upside for Savvy Investors

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a key player in the healthcare sector, specifically within the medical devices industry. The San Diego-based company has made..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth with a 12% Revenue Surge

For investors keeping an eye on the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a nuanced opportunity. With its focus on providing biological and chemical compound..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 84% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands out in the biotechnology sector with a compelling potential upside of 84.25%, making it a noteworthy consideration for investors seeking..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Ratings

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the healthcare sector, offers a suite of essential management and operational services to medical care facilities..

NewAmsterdam Pharma (NAMS) Stock Analysis: Unveiling a 154.62% Potential Upside in Biotech Innovation

NewAmsterdam Pharma Company N.V. (NAMS), headquartered in Naarden, the Netherlands, is a promising player in the biotechnology sector, focusing on innovative therapies for cardiometabolic and neurological..

NeoGenomics, Inc. (NEO) Stock Analysis: A 30% Upside Potential in the Healthcare Diagnostics Arena

For investors scouting opportunities in the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents a compelling case with a potential upside of nearly 31%. Positioned at the..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 23% Upside Potential and Robust Growth in Dermatological Treatments

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) has positioned itself as a noteworthy player within the biotechnology sector, focusing on innovative treatments for dermatological conditions. With its market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: High Potential with a 9.42% Upside

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing prospect. The company, operating within the medical care facilities..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A 27% Potential Upside Beckons Investors

For investors eyeing opportunities in the healthcare sector, Guardian Pharmacy Services, Inc. (GRDN) stands out with a compelling potential upside of 27.22%. This Atlanta-based company is..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 66% Upside Potential for Investors

Innoviva, Inc. (NASDAQ: INVA), a pivotal player in the biotechnology sector, is catching the attention of investors with its noteworthy performance metrics and promising financial outlook...

Integra LifeSciences Holdings (IART) Stock Analysis: Evaluating the 34% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a prominent player in the medical devices industry, operating within the broader healthcare sector. Based in the United States,..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a 19.71% Downside Amidst Promising Revenue Growth

BioLife Solutions, Inc. (NASDAQ: BLFS) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Bothell, Washington, the..

Wave Life Sciences, Inc. (WVE) Stock Analysis: A Biotech Gem with a 450% Potential Upside

Wave Life Sciences, Inc. (NASDAQ: WVE) is capturing investor attention with a compelling story in the biotechnology sector. With a market capitalization of $632.52 million, this..

PACS Group, Inc. (PACS) Stock Analysis: Strong Buy Ratings and 21% Upside Potential Highlight Investor Appeal

Investors seeking growth opportunities in the healthcare sector may find PACS Group, Inc. (PACS) particularly compelling. As a dominant player in the medical care facilities industry,..

Kestra Medical Technologies (KMTS) Stock Analysis: A Promising Healthcare Innovator with 59.9% Revenue Growth

Kestra Medical Technologies, Ltd. (KMTS), a United States-based company specializing in medical instruments and supplies, is making waves in the healthcare industry with its innovative approach..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: High Revenue Growth and a Promising Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a key player in the biotechnology industry, is turning heads with its impressive revenue growth and substantial potential upside. Specializing in..

Pulse Biosciences, Inc (PLSE) Stock Analysis: A Promising 18.37% Potential Upside Awaits Investors

Pulse Biosciences, Inc. (NASDAQ: PLSE), a trailblazing entity within the healthcare sector, is garnering significant attention from investors due to its innovative strides in bioelectric medicine...

ImmunityBio, Inc. (IBRX) Stock Analysis: 82% Potential Upside Sparks Investor Interest

Investors eyeing the biotechnology sector may want to pay close attention to ImmunityBio, Inc. (NASDAQ: IBRX), a San Diego-based innovator in the field of immunotherapy. With..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

Phreesia, Inc. (PHR) Stock Analysis: Potential 10.49% Upside with Strong Buy Ratings

Phreesia, Inc. (NYSE: PHR) is emerging as a noteworthy player in the healthcare sector, particularly within the health information services industry. With its market cap standing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds